Insights

Expansion momentum ClinChoice has a clear growth trajectory with recent acquisitions (CSI Medical Research in 2024) and strategic partnerships in Asia-Pacific and Australia, signaling opportunities to discuss full-service CRO collaborations with sponsors seeking global reach and integrated trial execution.

Asia-Pacific focus Active expansion in Asia-Pacific through open platform collaborations and a formal Australian MoU with Monash Health indicates a strong regional footprint. This presents sales potential with sponsors aiming to accelerate trials in APAC markets and leverage local regulatory and operational capabilities.

Global regulatory depth ClinChoice emphasizes deep regulatory, pharmacovigilance, and biometrics expertise across multiple regions, offering a compelling value proposition for sponsors needing robust compliance, safety monitoring, and data analytics for complex global trials.

Full-service capabilities Positioned as a global full- and functional-service CRO with end-to-end trial support, lifecycle management, and partnerships with academia and industry, enabling cross-sell of services to biopharma, medical devices, vaccines, and consumer health clients.

Financial and scale signals Revenue range ($500M–$1B) and a substantial fundraise ($212M) indicate financial stability and growth capacity, which can be leveraged to pursue larger, multi-project deals, strategic alliances, and longer-term engagements with mid-to-large sponsors seeking dependable CRO partners.

Similar companies to ClinChoice

ClinChoice Tech Stack

ClinChoice uses 8 technology products and services including iCIMS, SAS, Tableau, and more. Explore ClinChoice's tech stack below.

Media & News

ClinChoice's Email Address Formats

ClinChoice uses at least 2 email formats:
ClinChoice Email FormatsExamplePercentage
First.Last@clinchoice.comJohn.Doe@clinchoice.com
99%
First.MiddleLast@clinchoice.comJohn.MichaelDoe@clinchoice.com
1%

Frequently Asked Questions

What is ClinChoice's official website and social media links?

Minus sign iconPlus sign icon
ClinChoice's official website is clinchoice.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does ClinChoice generate?

Minus sign iconPlus sign icon
As of October 2026, ClinChoice's annual revenue is estimated to be $500M - $1B.

What is ClinChoice's NAICS code?

Minus sign iconPlus sign icon
ClinChoice's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does ClinChoice have currently?

Minus sign iconPlus sign icon
As of October 2026, ClinChoice has approximately 1.7K employees across 6 continents, including Asia, North America and Europe. Key team members include Coo, China: H. L., Chief Information Security Officer: S. D. and Chief Financial Officer: J. R. Explore ClinChoice's employee directory with LeadIQ.

What industry does ClinChoice belong to?

Minus sign iconPlus sign icon
ClinChoice operates in the Pharmaceutical Manufacturing industry.

What technology does ClinChoice use?

Minus sign iconPlus sign icon
ClinChoice's tech stack includes iCIMS, SAS, Tableau, HashiCorp Terraform, Microsoft 365, ADP, Microsoft Teams and VMware.

What is ClinChoice's email format?

Minus sign iconPlus sign icon
ClinChoice's email format typically follows the pattern of First.Last@clinchoice.com. Find more ClinChoice email formats with LeadIQ.

How much funding has ClinChoice raised to date?

Minus sign iconPlus sign icon
As of October 2026, ClinChoice has raised $212M in funding. The last funding round occurred on Jul 04, 2022 for $150M.

When was ClinChoice founded?

Minus sign iconPlus sign icon
ClinChoice was founded in 1995.
ClinChoice logo

ClinChoice

Pharmaceutical ManufacturingPennsylvania, United States1001-5000 Employees

ClinChoice is a global contract research organization offering full and functional service capabilities across pharmaceutical, biotechnology, medical device, and consumer health sectors. It is headquartered at 300 Welsh Road, Building 5, Suite 201, Horsham, Pennsylvania, United States, and employs between 1,001 and 5,000 people. The company provides regulatory expertise, clinical trial execution, pharmacovigilance, and biometrics as part of its product development and lifecycle management services, with a presence across the Americas, Europe, and Asia-Pacific. ClinChoice has expanded internationally through acquisitions, notably CSI Medical Research in January 2024 and Csimedicalresearch, and has established partnerships such as with Monash University in 2026 to support collaboration between academia and industry. With three decades of experience, ClinChoice supports clients across pharmaceutical, biotechnology, medical device, and consumer health sectors worldwide.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1995
Employees
1001-5000

Section iconFunding & Financials

  • $212M

    ClinChoice has raised a total of $212M of funding over 7 rounds. Their latest funding round was raised on Jul 04, 2022 in the amount of $150M as a Series E.

  • $500M - $1B

    ClinChoice's revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.